Marshall Wace Asia’s Hologic HOLX Stock Holding History

Marshall Wace Asia’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,407	Closed	-$1.85M	–	165
2020 Q4	$1.85M	Buy	+25,407	New	+$1.79M	0.03%	123

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Marshall Wace Asia's HOLX Position: Q1 2021 in Review

Marshall Wace Asia sold out of Hologic (HOLX) in Q1 2021, closing a stake of 25,407 shares — an estimated $1.85M sold.

Marshall Wace Asia first reported a position in HOLX in Q4 2020 and held it in 1 quarter. The position peaked at $1.85M in Q4 2020. 638 funds tracked by Wall St. Rank hold HOLX as of Q1 2021.

Marshall Wace Asia reported no remaining Hologic position as of Q1 2021 after selling out during the quarter.
Marshall Wace Asia sold 25,407 Hologic shares in Q1 2021, an estimated $1.85M.
Marshall Wace Asia first reported a position in Hologic in Q4 2020 and held it in 1 quarter.
Marshall Wace Asia's Hologic position peaked at $1.85M in Q4 2020.
638 funds tracked by Wall St. Rank held Hologic as of Q1 2021.

Based on Marshall Wace Asia's 13F filing for Q1 2021, filed 17 May 2021.